Investment Counsel’s Novartis NVS Stock Holding History

Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,361	Closed	-$470K	–	65
2016 Q2	$470K	Buy	+6,361	New	+$439K	0.38%	55

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Investment Counsel's NVS Position: Q3 2016 in Review

Investment Counsel sold out of Novartis (NVS) in Q3 2016, closing a stake of 6,361 shares — an estimated $470K sold.

Investment Counsel first reported a position in NVS in Q2 2016 and held it in 1 quarter. The position peaked at $470K in Q2 2016. 877 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

Investment Counsel reported no remaining Novartis position as of Q3 2016 after selling out during the quarter.
Investment Counsel sold 6,361 Novartis shares in Q3 2016, an estimated $470K.
Investment Counsel first reported a position in Novartis in Q2 2016 and held it in 1 quarter.
Investment Counsel's Novartis position peaked at $470K in Q2 2016.
877 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on Investment Counsel's 13F filing for Q3 2016, filed 10 Nov 2016.